These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21217370)

  • 41. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.
    Dayan SH; Arkins JP; Patel AB; Gal TJ
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Medical rhinoplasty: rationale for atraumatic nasal modelling using botulinum toxin and fillers].
    Braccini F; Dohan Ehrenfest DM
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):233-8. PubMed ID: 19408501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice.
    Carruthers J; Fournier N; Kerscher M; Ruiz-Avila J; Trindade de Almeida AR; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):510-25. PubMed ID: 23458295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining fillers and neuromodulators in the same syringe.
    Kenner J
    J Drugs Dermatol; 2014 Feb; 13(2):110. PubMed ID: 24509957
    [No Abstract]   [Full Text] [Related]  

  • 46. Combining fillers and neuromodulators in the same syringe.
    Cohen JL; Mariwall K
    J Drugs Dermatol; 2013 Sep; 12(9):976. PubMed ID: 24002142
    [No Abstract]   [Full Text] [Related]  

  • 47. Soft tissue augmentation 2006: filler fantasy.
    Klein AW
    Dermatol Ther; 2006; 19(3):129-33. PubMed ID: 16784511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers: Safety and Current Use.
    Fabi SG; Goldman MP; Mills DC; Werschler WP; Green JB; Kaufman J; Weiss RA; Hornfeldt CS
    Dermatol Surg; 2016 May; 42 Suppl 2():S168-76. PubMed ID: 27128245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face.
    de Maio M; Swift A; Signorini M; Fagien S;
    Plast Reconstr Surg; 2017 Aug; 140(2):265e-276e. PubMed ID: 28746271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face.
    de Maio M; Wu WTL; Goodman GJ; Monheit G;
    Plast Reconstr Surg; 2017 Sep; 140(3):393e-404e. PubMed ID: 28841604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erasing the years. An overview of dermal fillers.
    De Silva LW
    Adv Nurse Pract; 2006 Feb; 14(2):31-3. PubMed ID: 16471304
    [No Abstract]   [Full Text] [Related]  

  • 52. The actual role of hyaluronic acid-based and calcium hydroxylapatite soft tissue fillers: a guide for a practicing dermatologist.
    Pavlović M; Adamič M; Schuller Petrović S
    G Ital Dermatol Venereol; 2012 Jun; 147(3):295-314. PubMed ID: 22648331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urethral and bladder injections for incontinence including botox.
    Appell RA
    Urol Clin North Am; 2011 Feb; 38(1):1-6, v. PubMed ID: 21353073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Botulinum Toxin Aesthetic Outcomes: Clinical Study vs Real-World Practice.
    Glogau R; Biesman B; Kane M
    JAMA Dermatol; 2015 Nov; 151(11):1177-8. PubMed ID: 26375723
    [No Abstract]   [Full Text] [Related]  

  • 55. [The minimally invasive rhinoplasty with hyaluronic acid and botulinum toxin in a 49-year old woman].
    Modrzyński M; Ignaciuk A
    Otolaryngol Pol; 2010; 64(5):324-7. PubMed ID: 21166145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin A and/or soft tissue fillers for facial rehabilitation.
    Wollina U; Goldman A
    Wien Med Wochenschr; 2017 Mar; 167(3-4):92-95. PubMed ID: 27631872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
    Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.